loading page

Relapsed RUNX1-RUNX1T1-positive acute myeloid leukemia with pseudo-Chediak-Higashi granules and C-MYC amplification
  • +5
  • Hiroaki Kondo,
  • Takuyo Kanayama,
  • Utsuki Matsumura,
  • Takayo Urata,
  • Shinya Osone,
  • Toshihiko Imamura,
  • Tohru Inaba,
  • Hajime Hosoi
Hiroaki Kondo
Kyoto Prefectural University of Medicine

Corresponding Author:hkondo@koto.kpu-m.ac.jp

Author Profile
Takuyo Kanayama
National Hospital Organization Maizuru Medical Center
Author Profile
Utsuki Matsumura
National Hospital Organization Maizuru Medical Center
Author Profile
Takayo Urata
Kyoto Prefectural University of Medicine
Author Profile
Shinya Osone
Kyoto Prefectural University of Medicine
Author Profile
Toshihiko Imamura
Kyoto Prefectural University of Medicine
Author Profile
Tohru Inaba
Kyoto Prefectural University of Medicine
Author Profile
Hajime Hosoi
Kyoto Prefectural University of Medicine
Author Profile

Abstract

A 7-year-old boy was diagnosed with RUNX1-RUNX1T1-positive acute myeloid leukemia. Although he achieved complete remission (CR) after conventional chemotherapy, he experienced relapse 6 months after completing initial treatment. The cytoplasm of myeloblasts examined at relapse contained pink giant granules. These myeloperoxidase-positive granules were considered to be pseudo-Chediak-Higashi (PCH) granules. Meanwhile, blasts had acquired genetic alterations such as hypotetraploidy with RUNX1-RUNX1T1 and C-MYC amplification, and a KIT N822K mutation. The patient underwent cord blood transplantation and maintains a second CR. A previous report suggests that C-MYC amplification might be associated with PCH granule formation, and our case supports this hypothesis.